Sign in
CompletedNo phase

Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study

Key facts

Who runs it
University of California, San Francisco
Where
San Francisco, United StatesSee the site
Trial code
Status
Completed
People taking part
23 people enrolled
Started
12 Jun 2024
Ended
29 May 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Oral sedation
  • Placebo
Record updated
9 July 2026

Who can take part

Age
60 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • ≥ 60 years old
  • Capable of providing informed consent and completing the study procedures in English
  • Able to provide consent for oneself
  • Able to follow directions
  • Able to climb one flight of stairs without stopping to rest
  • Have a new diagnosis of cataract disease
  • Plan on having cataract surgery on their eye within the next 6 months

Who cannot take part

  • History of prior cataract surgery
  • Patient undergoing cataract surgery in combination with any other ophthalmologic procedure
  • Patient requiring general anesthesia during cataract surgery due to the underlying characteristics of the existing cataract and/or anticipated complexity of the planned procedure
  • Allergy or resistance to local anesthetic agents
  • History of severe anxiety requiring routine use of benzodiazepines
  • Severe valve disease (e.g., critical aortic stenosis)
  • Cardiac conditions requiring an implanted cardiac device such as a pacemaker, defibrillator, or left ventricular assist device (for arrhythmia, congestive heart failure, etc.)
  • Untreated chest pain or angina
  • Patients with movement disorders (e.g., Parkinson's Disease)
  • History of Cerebral Vascular Accident (CVA), Transient Ischemic Attack (TIA), or seizures
  • End-stage renal disease (ESRD) requiring dialysis
  • Admission to the hospital within the past 30 days
  • Difficulty being sedated during other minor outpatient procedures or imaging studies
  • Cannot lay flat on your back without having symptoms (i.e., difficulty breathing, severe back pain, etc.)
  • Require home oxygen (O2) at rest or with exertion
  • Morbid obesity (BMI>35)

Where in United States

  • University of California San FranciscoSan Francisco, United States

About the trial

What the trial wants to find out

The goal of this pilot clinical trial comparing two different sedation approaches for cataract surgery is to assess the feasibility, completeness, and distribution of data in measuring patient satisfaction, the quality of recovery, and surgical outcomes for the purpose of planning a larger clinical trial. Participants will be asked to respond to several surveys throughout the study on their experience and to assess outcomes of interest.

The 2 groups in the trial

  • InterventionTreatment being tested

    Oral sedation will be administered to patients prior to the procedure.

    Treatment: Oral sedation

  • PlaceboPlacebo, for comparison

    An oral placebo pill will be administered to patients prior to the procedure.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparing Two Normal Approaches to Procedural Sedation for Cataract Surgery: A Prospective, Feasibility Pilot Study
Record updated
9 July 2026